Evidence that the IGFBP-5 protein contributes to the development of pulmonary fibrosis was supported by new research finding that its…
Articles by Stacy Grieve, PhD
Results from the long-term PASSPORT clinical study are consistent with the known safety profile of Esbriet (pirfenidone), further strengthening…
A recent study in mice shows that endometrial regenerative cells (ERCs) can ease some of the common symptoms of…
An anti-inflammatory agent known as ulinastatin decreases pulmonary fibrosis, and at high doses may protect against lung tissue scarring, a…
Esbriet (pirfenidone) was as effective as prednisone and better than acetylcysteine at inhibiting inflammation and fibrosis in the lungs of rats with idiopathic…
Although previously limited to the pulmonary system, new research suggests that acute exacerbations in idiopathic pulmonary fibrosis (IPF) also involve…